|LNTH||LANTHEUS HOLDINGS INC||2.40%|
|NVO||NOVO NORDISK A/S||2.35%|
|APLS||APELLIS PHARMACEUTICALS INC||2.23%|
|BIO||BIO-RAD LABORATORIES INC||2.15%|
|SRPT||SAREPTA THERAPEUTICS INC||2.10%|
|IDXX||IDEXX LABS CORP||1.97%|
|TMO||THERMO FISHER SCIENTIFIC INC||1.93%|
|HCA||HCA HOLDINGS INC||1.93%|
|OPCH||OPTION CARE HEALTH, INC.||1.89%|
|ZBH||ZIMMER BIOMET HOLDINGS INC||1.88%|
|ITCI||INTRA-CELLULAR THERAPIES USD||1.86%|
|BMRN||BIOMARIN PHARAMCEUTICAL INC||1.85%|
|VRTX||VERTEX PHARMACEUTICALS INC||1.78%|
|JAZZ||JAZZ PHARMACEUTICALS PLC||1.66%|
|ADUS||ADDUS HOMECARE CORPORATION||1.65%|
|UNH||UNITEDHEALTH GROUP INC||1.61%|
|MRVI||MARAVAI LIFESCIENCES HOLDINGS, INC. (CLASS A)||1.60%|
|ALNY||ALNYLAM PHARMACEUTICALS INC.||1.56%|
|IQV||IQVIA HOLDINGS INC||1.56%|
|LLY||ELI LILLY CORP||1.55%|
|JNJ||JOHNSON & JOHNSON||1.49%|
|ACHC||ACADIA HEALTHCARE CO INC||1.47%|
|CERE||CEREVEL THERAPEUTICS HLD||1.43%|
|NBIX||NEUROCRINE BIOSCIENCES INC||1.42%|
|UTHR||UNITED THERAPEUTICS CORPS||1.38%|
|GMED||GLOBUS MEDICAL INC CLASS A||1.37%|
|MOH||MOLINA HEALTHCARE INC||1.37%|
|CRL||CHARLES RIVER LABORATORIES INT INC||1.36%|
|CI||THE CIGNA GROUP||1.31%|
|NTLA||INTELLIA THERAPEUTICS INC||1.28%|
|DNLI||DENALI THERAPEUTICS INC.||1.25%|
|BCRX||BIOCRYST PHARMACEUTICALS INC||1.16%|
|TWST||TWIST BIOSCIENCE CORP USD 0.00001||1.02%|
|ABCL||ABCELLERA BIOLOGICS INC NPV||0.90%|
|ARVN||ARVINAS INC USD||0.89%|
|MRTX||MIRATI THERAPEUTICS INC||0.82%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2023 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.